Shares in Minerva Neurosciences have lost more than half their value after the FDA rejected its marketing application for roluperidone as a treatment for the negative symptoms of schizophrenia. In a ...

The demand for smarter and more precise AI creative tools is growing fast. Creators today don't just want beautiful images ? they want consistency, storytelling, and control across every project. To ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...